The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSomero Regulatory News (SOM)

Share Price Information for Somero (SOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 335.00
Bid: 330.00
Ask: 340.00
Change: 3.00 (0.90%)
Spread: 10.00 (3.03%)
Open: 335.00
High: 335.00
Low: 335.00
Prev. Close: 332.00
SOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 Update

5 Jun 2020 07:00

RNS Number : 0063P
Somero Enterprises Inc.
05 June 2020
 

5 June 2020

Somero Enterprises, Inc.

("Somero" or the "Company")

 

COVID-19 Update

Somero® provides the following update on trading and the precautionary actions carried out by the Company in response to the evolving COVID-19 pandemic.

While the Company remains in a strong financial position, because the implications and duration of the COVID-19 pandemic remain difficult to determine, in addition to the previously announced measures, the Company is implementing a range of further precautionary actions to reduce costs and conserve cash during this period of uncertainty.

The Board remains confident in the health of the business and its growth prospects over the long-term and is taking these actions now to ensure the business is in a strong position once the operating environment becomes more normal.

Management actions

As of the date of this update, management has taken the following additional actions, all of which will be kept under constant review as circumstances change:

· Furloughing approximately 20% of our workforce

· Cancelling of all bonus and profit-sharing payments for the calendar year 2020, a decision that impacts all Somero employees not on sales commission plans

· Curtailing discretionary spending across all departments

· Curtailing further capital expenditure beyond what has already been committed to on-going building expansion projects

The annualized pre-tax impact of these cost saving measures is expected to approximate US$ 5.0m.

Financial position and cash management

Somero entered this period of uncertainty with a strong balance sheet and good liquidity and its financial position has been strengthened further by these additional financial and cost saving measures. On 30 March, the Company indicated its net cash position exceeded US$ 24.0m. Management expects its net cash position at the end of 30 June will continue to exceed US$ 24.0m and the Company continues to have access to substantial additional liquidity through its US$ 10.0m line of credit. In addition, the Company will continue to closely monitor, and pursue as applicable, all US government funding opportunities for which the Company may be eligible.

Current trading and outlook

Even though the COVID-19 pandemic has resulted in current trading that has fallen approximately 25% below levels required to achieve the market expectation at the start of the year of US$ 90.0m in 2020 revenues, the Company remains profitable and cash generative. The Board is confident that, following the actions taken by the Company described above, the Company would continue to be cash generative even in the scenario where revenues fall an additional 20% from current levels, to approximately $54.0m, which provides Management substantial flexibility during this challenging period.

Uncertainty around the scale, duration and impact of the COVID-19 pandemic on Somero's end markets in the non-residential construction industry, makes it difficult at this time to provide further guidance on the Company's financial performance in the rest of 2020 and beyond. While extended project backlogs reported by our customers prior to the COVID-19 pandemic, particularly in the US, indicate the non-residential construction market was active and healthy entering this period, financial performance for 2020 and beyond will depend on a number variables over which the Company has no control.

Somero's operating model enables the Company to adjust quickly to changing conditions, protect profitability and preserve its strong financial position. In addition, it is important to highlight that the cost saving actions taken by management are specifically designed to not impact investment in new product development, a key element to the Company's long-term growth strategy. In fact, new product development activity remains at the high level seen in recent years.

The range and depth of impact from the COVID-19 pandemic creates significant short-term uncertainty, but the Board remains confident in the health of our business and the long-term growth opportunities in front of us. The Company is positioned well to withstand impacts from COVID-19, benefitting from a strong financial position, a flexible operating model, and a continued pipeline of new products to fuel growth, until such time as non-residential construction activity reverts to more normalized activity.

The Company will hold its Annual General Meeting on June 9, 2020 at 9 am local time via webcast. Registration information can be found at https://investors.somero.com/.

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

 

Enquiries:

 

Somero Enterprises, Inc. www.somero.com

Jack Cooney, CEO +1 239 210 6500

John Yuncza, CFO

Howard Hohmann, EVP Sales

 

finnCap Ltd (NOMAD and Broker)

Matt Goode (Corporate Finance) +44 (0)20 7220 0500

Carl Holmes (Corporate Finance)

Kate Bannatyne (Corporate Finance)

Tim Redfern (Corporate Broking)

 

Alma PR (Financial PR Advisor) somero@almapr.co.uk

Rebecca Sanders-Hewett +44 (0) 2034 050 205

Susie Hudson

Sam Modlin

David Ison

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSSDFDLESSESM
Date   Source Headline
4th Dec 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Dec 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Nov 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Nov 20207:00 amRNSTrading Statement
13th Nov 20204:22 pmRNSHolding(s) in Company
11th Nov 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Nov 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Nov 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Oct 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Oct 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Oct 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Oct 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Sep 20207:00 amRNSHolding(s) in Company
29th Sep 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Sep 20203:49 pmRNSTransactions in Own Shares
22nd Sep 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Sep 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
9th Sep 20209:05 amRNSSecond Price Monitoring Extn
9th Sep 20209:00 amRNSPrice Monitoring Extension
9th Sep 20207:00 amRNSInterim Results
13th Aug 20205:22 pmRNSHolding(s) in Company
4th Aug 20201:53 pmRNSHolding(s) in Company
14th Jul 20207:00 amRNSTrading Update
23rd Jun 20201:54 pmRNSHolding(s) in Company
10th Jun 20207:00 amRNSResult of AGM
8th Jun 20207:00 amRNSAGM Statement
5th Jun 20207:00 amRNSCOVID-19 Update
26th May 20207:00 amRNSAnnual Report Correction - Replacement
22nd May 20205:30 pmRNSAnnual Report Correction
16th Apr 20207:00 amRNSAnnual Report, AGM Notice & QCA CG Code Adoption
30th Mar 20207:00 amRNSCOVID-19 Update
25th Mar 202011:05 amRNSSecond Price Monitoring Extn
25th Mar 202011:00 amRNSPrice Monitoring Extension
25th Mar 20209:00 amRNSPrice Monitoring Extension
20th Mar 20204:45 pmRNSSecond Price Monitoring Extn
20th Mar 20204:37 pmRNSPrice Monitoring Extension
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:38 pmRNSPrice Monitoring Extension
18th Mar 20207:00 amRNSTransactions in Own Shares and RSUs
16th Mar 202011:05 amRNSSecond Price Monitoring Extn
16th Mar 202011:00 amRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSTransactions in Own Shares and RSUs
12th Mar 20204:44 pmRNSSecond Price Monitoring Extn
12th Mar 20204:38 pmRNSPrice Monitoring Extension
12th Mar 202012:41 pmRNSShare Buyback Programme
11th Mar 20207:00 amRNSFinal Results
9th Mar 20202:06 pmRNSSecond Price Monitoring Extn
9th Mar 20202:01 pmRNSPrice Monitoring Extension
6th Mar 20202:19 pmRNSHolding(s) in Company
22nd Jan 20202:58 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.